Response to "distinguishing hemophagocytic lymphohistiocytosis from hemochromatosis in patients with hyperferritinemia"

Pediatric Blood and Cancer

Volumn 50, Issue 6, 2008, Pages 1287-1288

  McClain, Kenneth L ^a,b   Allen, Carl E ^b   Kozinetz, Claudia ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

BLEEDING; BONE MARROW TRANSPLANTATION; CELL SECRETION; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; FEVER; HEMOCHROMATOSIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; IMMUNOTHERAPY; KIDNEY FAILURE; LETTER; PEDIATRICS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SYMPTOM;

EID: 42349102849     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21541     Document Type: Letter

References (3)

1. Kwak EL, Larochelle DA, Beaumont C, et al. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 1995;270:15285-15293.
2. Henter J-I, Horne AC, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemohagocytic lymphohistiocytosis. Pedatr Blood Cancer 2007;48:124-131.
3. Mahlaoui N, Ouachee-Chardin M, de Saint Basile G, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: A single-center retrospective report for 38 patients. Pediatrics 2007;120:e622-e628.